396064000: Fluticasone propionate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\...

\Glucocorticoid (substance)\Fluticasone propionate (substance)

\Fluorinated corticosteroid\Fluticasone propionate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Fluticasone propionate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluticasone propionate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Steroid hormone\Glucocorticoid (substance)\Fluticasone propionate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Steroid hormone\Fluorinated corticosteroid\Fluticasone propionate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid (substance)\...

\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Fluticasone propionate (substance)
\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluticasone propionate (substance)

\Androstane\Fluticasone propionate (substance)

\Steroid hormone\Glucocorticoid (substance)\Fluticasone propionate (substance)
\Steroid hormone\Fluorinated corticosteroid\Fluticasone propionate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1470004013 Fluticasone propionate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489689017 Fluticasone propionate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4502611000005111 Fluticasonpropionat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fluticasone propionate (substance)	Is a	Antiinflammatorisk middel	false	Inferred relationship	Some
Fluticasone propionate (substance)	Is a	Fluticasone (substance)	false	Inferred relationship	Some
Fluticasone propionate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Fluticasone (substance)	true	Inferred relationship	Some
Fluticasone propionate (substance)	Is a	respiratorisk corticosteroid	false	Inferred relationship	Some
Fluticasone propionate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Androgen receptor agonist (disposition)	false	Inferred relationship	Some
Fluticasone propionate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Gonadal hormone	false	Inferred relationship	Some
Fluticasone propionate (substance)	Is a	Androstane	true	Inferred relationship	Some
Fluticasone propionate (substance)	Is a	Fluorinated corticosteroid	true	Inferred relationship	Some
Fluticasone propionate (substance)	Is a	Glucocorticoid (substance)	true	Inferred relationship	Some
Fluticasone propionate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fluticasone propionate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate topical preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate [respiratory use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 50 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 100 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 250 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 50 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 100 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 250 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 25 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 50 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 125 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 250 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 500 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 500 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 50 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 500 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 0,5 mg/2 ml nebulisatorampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 2 mg/2 ml nebulisatorampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 125 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 250 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 50 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 50 µg vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 400 µg næsedråber til engangsbrug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate[skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 500 microgram/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 50 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 44 µg inhalation aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 110 µg inhalation aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticasonpropionat 220 µg inhalation aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 0.05% spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 9g spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 110mcg powder for inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 44mcg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 110mcg/spray aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 110mcg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 220mcg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 220mcg/spray aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 44mcg/inh aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 50mcg/spray spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 125mcg/spr inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 250mcg/spr inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 50mcg/spr inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Salmeterol+fluticasone propionate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 50 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 125 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 0500 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
fluticason til respirationssystemet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone-containing product in nasal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone [nose]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Product containing fluticasone and salmeterol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 50 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 125 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 0500 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Product containing fluticasone and salmeterol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate (substance)	Inferred relationship	Some
Fluticasone propionate 500 microgram/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 500 microgram/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/actuation nasal spray	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/actuation nasal spray	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 125 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 125 microgram/actuation pressurized suspension for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 250 microgram/actuation powder for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 250 microgram/actuation powder for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 100 microgram/actuation powder for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 100 microgram/actuation powder for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 500 microgram/actuation powder for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 500 microgram/actuation powder for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/actuation powder for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/actuation powder for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Fluticasone propionate (substance)	Inferred relationship	Some	1
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	2
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	2
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	2
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	2
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluticasone propionate (substance)	Inferred relationship	Some	2
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	2
Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluticasone propionate (substance)	Inferred relationship	Some	2

Page 1 of 2 End

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1470004013	Fluticasone propionate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489689017	Fluticasone propionate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4502611000005111	Fluticasonpropionat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)